HilleVax, Inc. financial data

Symbol
HLVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Ave, Suite 500, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 882 % -46.4%
Debt-to-equity 29.4 % +23.8%
Return On Equity -67.3 % -60.3%
Return On Assets -52 % -53.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +2.83%
Common Stock, Shares, Outstanding 49.5M shares +4.32%
Entity Public Float 258M USD +13.3%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49.4M shares +26.5%
Weighted Average Number of Shares Outstanding, Diluted 49.4M shares +26.5%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 29.9M USD +18.7%
Operating Income (Loss) -159M USD -37.3%
Nonoperating Income (Expense) 9.15M USD +9.48%
Net Income (Loss) Attributable to Parent -150M USD -39.4%
Earnings Per Share, Basic -3.1 USD/shares -171%
Earnings Per Share, Diluted -3.1 USD/shares -171%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 104M USD -50.2%
Marketable Securities, Current 85.5M USD -26.2%
Assets, Current 197M USD -40.8%
Property, Plant and Equipment, Net 9.78M USD -28.9%
Operating Lease, Right-of-Use Asset 12M USD -34.6%
Other Assets, Noncurrent 24K USD +9.09%
Assets 221M USD -39.9%
Accounts Payable, Current 1.21M USD -63.2%
Employee-related Liabilities, Current 587K USD -84.3%
Accrued Liabilities, Current 9.08M USD -29.5%
Liabilities, Current 13.8M USD -27%
Operating Lease, Liability, Noncurrent 21.4M USD -7.83%
Other Liabilities, Noncurrent 1.09M USD -0.91%
Liabilities 36.3M USD -46.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -821K USD -139%
Retained Earnings (Accumulated Deficit) -502M USD -42.7%
Stockholders' Equity Attributable to Parent 184M USD -38.3%
Liabilities and Equity 221M USD -39.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33M USD -107%
Net Cash Provided by (Used in) Financing Activities 15.1M USD -81.2%
Net Cash Provided by (Used in) Investing Activities -57.7M USD -1832%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.8M shares +2.84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -75.6M USD -301%
Interest Paid, Excluding Capitalized Interest, Operating Activities 382K USD +99%
Deferred Tax Assets, Valuation Allowance 54.5M USD +102%
Deferred Tax Assets, Gross 58.4M USD +86.2%
Operating Lease, Liability 25M USD -3.58%
Depreciation 1.73M USD +25%
Payments to Acquire Property, Plant, and Equipment 153K USD -94.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -151M USD -39.4%
Lessee, Operating Lease, Liability, to be Paid 33.3M USD -9.63%
Property, Plant and Equipment, Gross 12.1M USD -15.1%
Operating Lease, Liability, Current 3.55M USD +33.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.69M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 897K USD +2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.34M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.79M USD +2.68%
Deferred Tax Assets, Operating Loss Carryforwards 10.3M USD +48.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 959K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.86M USD +2.01%
Operating Lease, Payments 896K USD +2.87%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.94M USD -11.6%
Share-based Payment Arrangement, Expense 20.1M USD +79.7%
Interest Expense 2.91M USD +106%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%